Hong Kong stocks gain as technology and pharmaceutical shares lead the market

Fidelity China Special Situations

Hong Kong shares moved higher on Tuesday, with pharmaceutical and technology stocks leading gains as stronger global market sentiment offset continued weakness among property developers.

The Hang Seng Index was up 0.8% at 24,240 by the latest reported level, while the Hang Seng China Enterprises Index gained 0.82%. The Hang Seng Tech Index rose 0.87%, while the Hang Seng Biotech Index advanced by almost 3%. The gains followed a stronger session on Wall Street, where technology stocks benefited from continued optimism surrounding artificial intelligence and corporate deal activity.

The technology-led move provides a further indication that investor attention remains concentrated on companies with exposure to artificial intelligence, technology and biotechnology. WuXi Biologics and Sino Biopharmaceutical were among the strongest performers within the Hang Seng Index, rising 4.2% and 4.1% respectively. Sunny Optical, Baidu, Kuaishou and Alibaba also recorded gains of between 2.8% and 3.7%.

Other technology-related names also moved higher. Z.AI Co. gained 7.8%, while Tencent rose 1%. Genscript Biotech advanced 5.5%, MiniMax increased 4.3% and Wuxi Biologics gained 3.3%.

The broader market was also supported by lower oil prices. Brent crude was trading around US$100 a barrel after falling 1.9% in the previous session, with increased Middle East exports and a commitment from G7 nations to boost supplies helping to ease some pressure on energy markets.

The move in Hong Kong followed a positive session in US markets, where the Nasdaq reached a record close. The technology rally has provided support for Asian markets, although higher US Treasury yields remain a consideration for equity valuations. Treasury yields were hovering around 5.31%, keeping interest rate and funding conditions firmly in focus.

Fidelity China Special Situations PLC (LON:FCSS), the UK’s largest China Investment Trust, capitalises on Fidelity’s extensive, locally-based analyst team to find attractive opportunities in a market too big to ignore.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

China shares edge higher as Beijing signals further market support

China's stock market recovery will depend on whether policy support translates into stronger economic activity and corporate earnings....

Fidelity China Special Situations highlights resilient exports and high-end manufacturing (LON: FCSS)

Fidelity China Special Situations PLC highlighted opportunities in China's AI sector and recent government measures to support the property...

China steps up stock market support as Asian shares recover

Chinese shares rise as Beijing prepares further stock market support, offsetting weak manufacturing data. South Korean technology stocks also...

China and Hong Kong stocks rebound as AI optimism lifts technology shares

China and Hong Kong stocks rebound as AI optimism lifts robotics, semiconductor and technology shares, while investors monitor domestic...

China equities gain as stronger economic data lifts sentiment

Chinese shares closed higher after GDP growth reached 4.5% in the third quarter, beating forecasts. Stronger retail sales and...

China stocks recover as AI buybacks and earnings forecasts support sentiment

China's equities rebounded from 14-month lows as AI-related companies announced share buybacks and stronger profit forecasts, although the market...

Search